{"id":"NCT00300430","sponsor":"Abbott","briefTitle":"Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.","officialTitle":"A Long-Term, Open-Label, Safety Extension Study of the Combination of Fenofibric Acid and Statin Therapy for Subjects With Mixed Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-09","primaryCompletion":"2008-03","completion":null,"firstPosted":"2006-03-09","resultsPosted":"2009-07-23","lastUpdate":"2009-07-23"},"enrollment":1911,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Dyslipidemia","Coronary Heart Disease","Mixed Dyslipidemia"],"interventions":[{"type":"DRUG","name":"ABT-335 and rosuvastatin calcium","otherNames":["ABT-335","TRILIPIX"]},{"type":"DRUG","name":"ABT-335 and atorvastatin calcium","otherNames":["ABT-335","TRILIPIX"]},{"type":"DRUG","name":"ABT-335 and simvastatin","otherNames":["ABT-335","TRILIPIX"]}],"arms":[{"label":"A","type":"ACTIVE_COMPARATOR"},{"label":"B","type":"ACTIVE_COMPARATOR"},{"label":"C","type":"ACTIVE_COMPARATOR"}],"summary":"The primary purpose of this study is to test the safety and the effects of using an investigational drug regimen; once daily ABT-335 (Investigational drug) administered in combination with once daily atorvastatin calcium, rosuvastatin calcium or simvastatin in patients with abnormal lipid levels in the blood.","primaryOutcome":{"measure":"Percentage of Subjects Reporting Adverse Events During Combination Therapy, Either in the Preceding Double-blind Studies or in This Open-label Study","timeFrame":"Anytime after initiation of combination therapy (either in the double-blind or open-label study) to within 30 days after the last dose of combination therapy","effectByArm":[{"arm":"ABT-335 + 20 mg Rosuvastatin","deltaMin":83,"sd":null},{"arm":"ABT-335 + 40 mg Simvastatin","deltaMin":86,"sd":null},{"arm":"ABT-335 + 40 mg Atorvastatin","deltaMin":85,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["22263674","18783301"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":85},"commonTop":["Headache","Upper respiratory tract infection","Nasopharyngitis","Back pain","Arthralgia"]}}